And while the exact molecular details of SIM2 action during development and beyond are still not entirely clear, it is known that Down syndrome patients have numerous amino acid changes in the SIM2 protein that in vitro impair its function as a transcription factor [24]. The gene discussed is SIM2; the disease is Down syndrome.